Röshammar D

Pharmetheus AB, Uppsala, Sweden.

3 papers

ArticleDMT

Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework.

Eckernäs E, Koomen J, Timmermann C +3

Europe PMC2023
ArticleDMT

N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis.

Eckernäs E, Timmermann C, Carhart-Harris R +2

Europe PMC2023
ArticleDMT

Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations.

Eckernäs E, Timmermann C, Carhart-Harris R +2

Europe PMC2022